{"name":"Jean-Pierre Van geertruyden","slug":"jean-pierre-van-geertruyden","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"MVA-BN half-dose regimen","genericName":"MVA-BN half-dose regimen","slug":"mva-bn-half-dose-regimen","indication":"Monkeypox (mpox) prevention in adults at risk of exposure","status":"phase_3"},{"name":"MVA-BN standard regimen","genericName":"MVA-BN standard regimen","slug":"mva-bn-standard-regimen","indication":"Monkeypox prevention in at-risk populations","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"AV2","genericName":"AV2","slug":"av2","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"MVA-BN half-dose regimen","genericName":"MVA-BN half-dose regimen","slug":"mva-bn-half-dose-regimen","phase":"phase_3","mechanism":"MVA-BN is a modified vaccinia Ankara-based vaccine expressing monkeypox antigens that primes the immune system to recognize and respond to monkeypox virus infection.","indications":["Monkeypox (mpox) prevention in adults at risk of exposure"],"catalyst":""},{"name":"MVA-BN standard regimen","genericName":"MVA-BN standard regimen","slug":"mva-bn-standard-regimen","phase":"phase_3","mechanism":"MVA-BN is a live attenuated vaccinia virus-based vaccine that stimulates immune responses against monkeypox virus antigens.","indications":["Monkeypox prevention in at-risk populations","Post-exposure prophylaxis for monkeypox"],"catalyst":""},{"name":"AV2","genericName":"AV2","slug":"av2","phase":"phase_3","mechanism":"AV2 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBMZm1oYVpiZWlyQ1lwZ3QtNWVfYldCVlFVTmZKY09Mb3pOcDVjY1cxQjVfN1FZUXBvRk9VcmVWc2JXYVlfSV9RejlRTlF2MmtDb1RZV0cyS2RZMXV4eW1FTThJV2Q1aU1WU2VGbW1OUUpqVDFhaDRrQ0lfNA?oc=5","date":"2024-09-28","type":"pipeline","source":"medrxiv.org","summary":"Decentralizing care for cutaneous leishmaniasis and other skin diseases in Southern Ethiopia: What are the needs? - medrxiv.org","headline":"Decentralizing care for cutaneous leishmaniasis and other skin diseases in Southern Ethiopia: What are the needs?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPa2tNMkhFQV9mQ1RnQmluWTRaSjZPTmJaVy0xQkNScWhqNkoxbGI0dGVJZVM4N3FCdTlMbjhuSUFSYWlNSkhyUGZCcUh5Z2FERDlkZVJWU2ExVkw1eF9DT09ra1pBWmlmVExUcDhMaENJS25sSkgtTWVhSk5YRGt2bDJXeVJGUW9XUFJwaDgyT2Q3RUZCZFBHVUpfSXZJeTJ6QktUM3FZQzktQWdFajduRUxKeU1ZYkZ2RGVTRHpGQ0Z3b0RyVXF2bXlJN1FfYnZ3TUhzWEdPcWxPb2xwc0E4dVJUOUlxQ2NSWjY3RnZYQnY?oc=5","date":"2023-11-27","type":"trial","source":"MyJoyOnline","summary":"Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rural settings - MyJoyOnline","headline":"Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rura","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}